Investing.comDoubao · 实盘不做把握 8/10不做原因:标的无直接敞口
北京时间·🕒 发布 20:04:33·⟳ 抓取 20:05:55 +1m22s·⚡ 决策 10-08 20:06:22 +27s·19.3 天前
Aardvark Therapeutics任命Abivax首席战略官David Zhang为独立董事
该事件只是补充一名具备临床和监管经验的独立董事，属于常规治理/人才任命；没有订单、临床数据、监管批准、融资、指引或控制权变化，不能形成短线正期望。
📄 原文Investing.com↗ 原文
Aardvark Therapeutics appoints David Zhang to board of directors
By Investing.com Advertisement Advertisement Aardvark Therapeutics appoints David Zhang to board of directors Company N…
不做 Aardvark Therapeutics, Inc.（AARD.US）
普通独立董事任命无金额、无管线状态迁移、无控制权变化，不能形成可交易预期差。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Aardvark Therapeutics宣布David Zhang担任独立董事。虽然其履历有助于临床与监管能力建设，但任命本身不改变公司资产、资金或关键试验状态，故不做交易。
🔎 新鲜度:最早出现 2026-10-08 · 扩散 low · price-in 风险 low ↗
关键理由
- 独立董事任命仅增强董事会经验，不构成收入、临床成功率或资产价值的可量化增量。
主要风险
- 若市场将其与后续临床进展或融资预期联想，小盘生物科技股可能出现短暂情绪波动，但缺乏可验证基本面依据。
反向证据
- 做多前查反向 · 来源 web · 日期 2026-10-08 · 影响 none
正文仅披露独立董事任命和个人履历，未包含临床数据、监管进展、融资或合作变化。
检索:Aardvark Therapeutics David Zhang board appointment clinical trial financing catalyst 原文 ↗
先例如何影响了这次决策
对本次决策的影响:先例缺失与事件机制共同支持AVOID，而非降低仓位试探。
方向:无可用于定价的高相似先例；普通董事任命通常不应被推断为明确正向催化。
涨幅量级:未获得同市场、同机制且锚点干净的先例，不能据此设定止盈幅度。
形态:未验证到反复见光死或高开模式；核心问题是事件本身缺少可交易增量。
原文全文
展开原文 · 7,519 字
Aardvark Therapeutics appoints David Zhang to board of directors By Investing.com
Advertisement
Advertisement
Aardvark Therapeutics appoints David Zhang to board of directors
Company News
Published
Oct 08, 2026, 08:04 AM
Aardvark Therapeutics appoints David Zhang to board of directors
View all comments (0)
0
Aardvark Therapeutics appoints David Zhang to board of directors
View all comments (0)
0
© Reuters
In this article:
AARD
-1.59%
SAN DIEGO -
Aardvark Therapeutics
, Inc. (
NASDAQ:AARD
) announced the appointment of David Zhang, Ph.D., MBA, to its Board of Directors as an independent director, effective Tuesday, according to a press release statement.
Zhang brings over 25 years of experience in clinical strategy, biostatistics and regulatory submissions. He currently serves as Chief Strategy Officer of Abivax S.A., a clinical-stage biotechnology company, where he is a member of the Executive Committee and oversees biometrics, regulatory affairs, quality assurance and health economics and outcomes research.
From 2021 to 2024, Zhang was Senior Vice President, Biometrics and Data Management at Alumis Inc., where he served as a founding executive and built the biometrics and data management functions. He also served as interim Chief Information Officer during the company’s initial public offering.
Zhang previously held the position of Vice President, Head of Biometrics, Data Science and Digital Health at MyoKardia, Inc., where he oversaw the pivotal trial design, readout and New Drug Application submission for CAMZYOS (mavacamten) for treating obstructive hypertrophic cardiomyopathy before Bristol Myers Squibb acquired the company.
Earlier in his career, Zhang held biometrics and strategic innovation leadership roles at Roche Sequencing Solutions and Genentech/Roche over a 15-year period, and statistician positions at Eli Lilly and Company and Abbott Laboratories.
Zhang holds a Ph.D. in biostatistics from the UCLA Fielding School of Public Health and an executive MBA in finance from the Kelley School of Business at Indiana University. He completed postdoctoral research in statistical genetics at Columbia University.
Aardvark is a clinical-stage biopharmaceutical company developing small-molecule therapeutics for the treatment of Prader-Willi Syndrome and metabolic diseases.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Aardvark Therapeutics appoints David Zhang to board of directors
View all comments (0)
0
Latest comments
Post
Comment Guidelines
Trade With A Regulated Broker
Indices
Commodities
Bonds
Stocks
US 30
50,811.50
-367.7
-0.72%
US 500
7,770.20
-31.5
-0.40%
Dow Jones
51,179.87
-341.41
-0.66%
S&P 500
7,801.77
-17.16
-0.22%
Nasdaq
27,538.69
-61.19
-0.22%
S&P 500 VIX
15.68
+0.60
+3.98%
Dollar Index
102.17
+0.157
+0.15%
Crude Oil WTI Futures
92.33
+4.05
+4.59%
Brent Oil Futures
104.74
+4.54
+4.53%
Natural Gas Futures
3.274
+0.071
+2.22%
Gold Futures
4,151.20
+10.50
+0.25%
Silver Futures
59.188
-1.106
-1.84%
Copper Futures
6.6473
-0.0022
-0.03%
US Soybeans Futures
1,294.25
-2.75
-0.21%
U.S. 10Y
5.331
+0.053
+1.00%
U.S. 30Y
5.702
+0.041
+0.72%
U.S. 5Y
5.075
+0.054
+1.08%
U.S. 3M
4.148
+0.007
+0.17%
US 10Y T-Note Futures
104.14
-0.34
-0.33%
Euro Bund Futures
120.63
-0.19
-0.15%
10-2 Yield Spread
31.32
+4.15
+15.27%
AAPL
336.67
+3.04
+0.91%
NVDA
237.47
-1.77
-0.74%
GOOGL
350.50
+2.82
+0.81%
TSLA
377.81
-2.87
-0.75%
AMZN
259.92
+3.63
+1.42%
NFLX
69.70
+1.01
+1.47%
META
721.31
-17.57
-2.38%
Advertisement
Most Popular Articles
News
Analysis
Citi names 5 top chip picks ahead of Q3 earnings
By Investing.co
...
Oct 08, 2026
Oil prices surge amid Mideast shipping attacks, U.S. Gulf coast disruptions
By Investing.co
...
Oct 08, 2026
AI debt deal wave reports; Applied Digital reports - what’s moving markets
By Investing.co
...
Oct 08, 2026
Wall Street posts first red session of October a day after notching a record close
By Investing.co
...
Oct 08, 2026
Samsung shares fall as record Q3 profit misses lofty expectations
By Investing.co
...
Oct 08, 2026
Micron Has Surged on the AI Boom - Is It Still a Buy?
By Antonio Rodr
...
Oct 06, 2026
9 Fundamentally Strong Stocks to Watch as Q3 Earnings Get Underway
By David Wagner
Oct 08, 2026
Nvidia Hits Another New High: Key Breakout and Retracement Targets to Watch
By Lee Yang
Oct 06, 2026
Worried Consumers Keep Spending: Here’s Why
By Michael Lebo
...
Oct 07, 2026
Q4 2026 Commodites Forecast: Will Gold and Silver Find a Bottom?
By Jeremy Wagne
...
Oct 07, 2026
More News
Market Movers
Most Active
Gainers %
Losers %
Name
Last
Chg. %
Vol.
MU
1,088.00
+4.06%
30.86M
NVDA
237.47
-0.74%
81.77M
SNDK
1,692.42
+1.92%
9.17M
SPCX
167.60
-2.51%
77.47M
AMD
645.86
-0.55%
18.56M
AAPL
336.67
+0.91%
34.15M
TSLA
377.81
-0.75%
25.59M
Name
Last
Chg. %
Vol.
NRG
108.61
+4.84%
5.39M
MRNA
196.48
+4.81%
14.64M
MU
1,088.00
+4.06%
30.86M
CTVA
14.45
+3.88%
41.33M
VST
166.72
+3.88%
12.01M
SMCI
44.94
+3.41%
40.54M
NTAP
235.77
+3.20%
3.00M
Name
Last
Chg. %
Vol.
MSTR
153.37
-6.79%
21.67M
SKYD
8.89
-6.72%
43.30M
CAT
813.83
-5.75%
3.34M
MHK
119.18
-5.45%
1.70M
NBIS
237.15
-5.09%
18.05M
CRWD
265.44
-4.81%
8.81M
BLDR
53.55
-4.75%
2.36M
Advertisement
Trending Stocks
Name
Last
Chg. %
Vol.
MU
1,088.00
+4.06%
30.86M
SPCX
167.60
-2.51%
77.47M
NVDA
237.47
-0.74%
81.77M
SNDK
1,692.42
+1.92%
9.17M
APLD
23.810
-6.04%
48.76M
Show more
Advertisement
ProPicks AI
AI-powered
stock picks
with a proven track record to
beat the S&P 500
.
Tech Titans
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Top Value Stocks
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Best of Buffett
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Energy Elite
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Financial Fortresses
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Quality Compounders
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Small-Cap Sprinters
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Healthcare Heroes
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Beat the S&P 500
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Dominate the Dow
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Mid-Cap Movers
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Mexican Stock Exchange Leaders
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Best Brazilian Stocks
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Italian Market Elite
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Alpha Germany Select
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Comments
Post
Comment Guidelines
Tools
Calendars
Economic Calendar
Earnings Calendar
Holiday Calendar
US Economy
Fed Rate Monitor Tool
US Treasury Yield Curve
More Tools
Stock Screener
Currency Converter
Markets
Ask WarrenAI
Stocks Picked by AI
Watchlist
Alerts
Top Brokers
Breaking News
Tools
Install Our App
Scan QR code to install app
Follow us
Advertisement
Advertisement
Aardvark Therapeutics appoints David Zhang to board of directors
Company News
Published
Oct 08, 2026, 08:04 AM
Aardvark Therapeutics appoints David Zhang to board of directors
View all comments (0)
0
Aardvark Therapeutics appoints David Zhang to board of directors
View all comments (0)
0
© Reuters
In this article:
AARD
-1.59%
SAN DIEGO -
Aardvark Therapeutics
, Inc. (
NASDAQ:AARD
) announced the appointment of David Zhang, Ph.D., MBA, to its Board of Directors as an independent director, effective Tuesday, according to a press release statement.
Zhang brings over 25 years of experience in clinical strategy, biostatistics and regulatory submissions. He currently serves as Chief Strategy Officer of Abivax S.A., a clinical-stage biotechnology company, where he is a member of the Executive Committee and oversees biometrics, regulatory affairs, quality assurance and health economics and outcomes research.
From 2021 to 2024, Zhang was Senior Vice President, Biometrics and Data Management at Alumis Inc., where he served as a founding executive and built the biometrics and data management functions. He also served as interim Chief Information Officer during the company’s initial public offering.
Zhang previously held the position of Vice President, Head of Biometrics, Data Science and Digital Health at MyoKardia, Inc., where he oversaw the pivotal trial design, readout and New Drug Application submission for CAMZYOS (mavacamten) for treating obstructive hypertrophic cardiomyopathy before Bristol Myers Squibb acquired the company.
Earlier in his career, Zhang held biometrics and strategic innovation leadership roles at Roche Sequencing Solutions and Genentech/Roche over a 15-year period, and statistician positions at Eli Lilly and Company and Abbott Laboratories.
Zhang holds a Ph.D. in biostatistics from the UCLA Fielding School of Public Health and an executive MBA in finance from the Kelley School of Business at Indiana University. He completed postdoctoral research in statistical genetics at Columbia University.
Aardvark is a clinical-stage biopharmaceutical company developing small-molecule therapeutics for the treatment of Prader-Willi Syndrome and metabolic diseases.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Aardvark Therapeutics appoints David Zhang to board of directors
View all comments (0)
0
Latest comments
Post
Comment Guidelines
Trade With A Regulated Broker
Indices
Commodities
Bonds
Stocks
US 30
50,811.50
-367.7
-0.72%
US 500
7,770.20
-31.5
-0.40%
Dow Jones
51,179.87
-341.41
-0.66%
S&P 500
7,801.77
-17.16
-0.22%
Nasdaq
27,538.69
-61.19
-0.22%
S&P 500 VIX
15.68
+0.60
+3.98%
Dollar Index
102.17
+0.157
+0.15%
Crude Oil WTI Futures
92.33
+4.05
+4.59%
Brent Oil Futures
104.74
+4.54
+4.53%
Natural Gas Futures
3.274
+0.071
+2.22%
Gold Futures
4,151.20
+10.50
+0.25%
Silver Futures
59.188
-1.106
-1.84%
Copper Futures
6.6473
-0.0022
-0.03%
US Soybeans Futures
1,294.25
-2.75
-0.21%
U.S. 10Y
5.331
+0.053
+1.00%
U.S. 30Y
5.702
+0.041
+0.72%
U.S. 5Y
5.075
+0.054
+1.08%
U.S. 3M
4.148
+0.007
+0.17%
US 10Y T-Note Futures
104.14
-0.34
-0.33%
Euro Bund Futures
120.63
-0.19
-0.15%
10-2 Yield Spread
31.32
+4.15
+15.27%
AAPL
336.67
+3.04
+0.91%
NVDA
237.47
-1.77
-0.74%
GOOGL
350.50
+2.82
+0.81%
TSLA
377.81
-2.87
-0.75%
AMZN
259.92
+3.63
+1.42%
NFLX
69.70
+1.01
+1.47%
META
721.31
-17.57
-2.38%
Advertisement
Most Popular Articles
News
Analysis
Citi names 5 top chip picks ahead of Q3 earnings
By Investing.co
...
Oct 08, 2026
Oil prices surge amid Mideast shipping attacks, U.S. Gulf coast disruptions
By Investing.co
...
Oct 08, 2026
AI debt deal wave reports; Applied Digital reports - what’s moving markets
By Investing.co
...
Oct 08, 2026
Wall Street posts first red session of October a day after notching a record close
By Investing.co
...
Oct 08, 2026
Samsung shares fall as record Q3 profit misses lofty expectations
By Investing.co
...
Oct 08, 2026
Micron Has Surged on the AI Boom - Is It Still a Buy?
By Antonio Rodr
...
Oct 06, 2026
9 Fundamentally Strong Stocks to Watch as Q3 Earnings Get Underway
By David Wagner
Oct 08, 2026
Nvidia Hits Another New High: Key Breakout and Retracement Targets to Watch
By Lee Yang
Oct 06, 2026
Worried Consumers Keep Spending: Here’s Why
By Michael Lebo
...
Oct 07, 2026
Q4 2026 Commodites Forecast: Will Gold and Silver Find a Bottom?
By Jeremy Wagne
...
Oct 07, 2026
More News
Market Movers
Most Active
Gainers %
Losers %
Name
Last
Chg. %
Vol.
MU
1,088.00
+4.06%
30.86M
NVDA
237.47
-0.74%
81.77M
SNDK
1,692.42
+1.92%
9.17M
SPCX
167.60
-2.51%
77.47M
AMD
645.86
-0.55%
18.56M
AAPL
336.67
+0.91%
34.15M
TSLA
377.81
-0.75%
25.59M
Name
Last
Chg. %
Vol.
NRG
108.61
+4.84%
5.39M
MRNA
196.48
+4.81%
14.64M
MU
1,088.00
+4.06%
30.86M
CTVA
14.45
+3.88%
41.33M
VST
166.72
+3.88%
12.01M
SMCI
44.94
+3.41%
40.54M
NTAP
235.77
+3.20%
3.00M
Name
Last
Chg. %
Vol.
MSTR
153.37
-6.79%
21.67M
SKYD
8.89
-6.72%
43.30M
CAT
813.83
-5.75%
3.34M
MHK
119.18
-5.45%
1.70M
NBIS
237.15
-5.09%
18.05M
CRWD
265.44
-4.81%
8.81M
BLDR
53.55
-4.75%
2.36M
Advertisement
Trending Stocks
Name
Last
Chg. %
Vol.
MU
1,088.00
+4.06%
30.86M
SPCX
167.60
-2.51%
77.47M
NVDA
237.47
-0.74%
81.77M
SNDK
1,692.42
+1.92%
9.17M
APLD
23.810
-6.04%
48.76M
Show more
Advertisement
ProPicks AI
AI-powered
stock picks
with a proven track record to
beat the S&P 500
.
Tech Titans
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Top Value Stocks
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Best of Buffett
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Energy Elite
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Financial Fortresses
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Quality Compounders
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Small-Cap Sprinters
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Healthcare Heroes
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Beat the S&P 500
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Dominate the Dow
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Mid-Cap Movers
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Mexican Stock Exchange Leaders
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Best Brazilian Stocks
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Italian Market Elite
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Alpha Germany Select
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Comments
Post
Comment Guidelines
Tools
Calendars
Economic Calendar
Earnings Calendar
Holiday Calendar
US Economy
Fed Rate Monitor Tool
US Treasury Yield Curve
More Tools
Stock Screener
Currency Converter
Markets
Ask WarrenAI
Stocks Picked by AI
Watchlist
Alerts
Top Brokers
Breaking News
Tools
Install Our App
Scan QR code to install app
Follow us
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。